康缘药业
(600557)
| 流通市值：114.54亿 | | | 总市值：115.78亿 |
| 流通股本：5.78亿 | | | 总股本：5.85亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,046,174,149.11 | 1,969,272,883.32 | 1,494,166,187.33 | 1,977,320,416.17 |
| 应收票据及应收账款 | 695,435,384.39 | 653,766,073.68 | 660,177,912.42 | 664,315,148.43 |
| 应收账款 | 695,435,384.39 | 653,766,073.68 | 660,177,912.42 | 664,315,148.43 |
| 应收款项融资 | 537,032,379.23 | 442,229,504.99 | 310,194,767 | 544,792,088.15 |
| 预付款项 | 25,425,535.39 | 28,626,350.98 | 85,350,370.66 | 44,429,852.17 |
| 其他应收款合计 | 13,735,844.26 | 5,315,921.09 | 7,927,617.64 | 12,412,154.35 |
| 存货 | 395,815,182.73 | 350,108,245.14 | 361,300,292.35 | 338,605,472.61 |
| 其他流动资产 | 58,585,240.58 | 73,361,887.19 | 1,893,157.41 | 7,626,723.29 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 4,222,203,715.69 | 4,049,719,426.38 | 3,631,010,304.81 | 3,771,501,855.17 |
| 非流动资产: | | | | |
| 长期股权投资 | 4,109,073.55 | 4,109,073.55 | 4,108,832.17 | 4,108,832.17 |
| 其他非流动金融资产 | 11,210,107.4 | 11,210,107.4 | 18,729,806.4 | 25,581,468.4 |
| 固定资产 | 2,243,783,439.56 | 2,280,740,570.47 | 2,341,926,388.89 | 2,358,309,047.14 |
| 在建工程 | 254,922,876.61 | 227,250,218.26 | 197,700,912.56 | 134,286,081.8 |
| 无形资产 | 190,305,473.33 | 197,380,959.08 | 214,469,762.18 | 216,224,986.01 |
| 开发支出 | 172,766,086.8 | 171,701,113.32 | 165,962,371.46 | 168,798,172.2 |
| 商誉 | 58,988,858.14 | 58,988,858.14 | 58,988,858.14 | 58,988,858.14 |
| 长期待摊费用 | 13,624,364.49 | 14,403,249.06 | 15,280,735.82 | 16,059,721.59 |
| 递延所得税资产 | 50,609,287.5 | 46,222,809.14 | 27,461,382.12 | 27,636,912.26 |
| 其他非流动资产 | 157,447,890.13 | 55,595,282.72 | 20,228,520.67 | 22,857,441.03 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,157,767,457.51 | 3,067,602,241.14 | 3,064,857,570.41 | 3,032,851,520.74 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 7,379,971,173.2 | 7,117,321,667.52 | 6,695,867,875.22 | 6,804,353,375.91 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 253,754,564.94 | 228,418,638.9 | 204,236,140.05 | 230,337,890.17 |
| 其中：应付票据 | - | - | - | 7,498,598.35 |
| 应付账款 | 253,754,564.94 | 228,418,638.9 | 204,236,140.05 | 222,839,291.82 |
| 合同负债 | 16,097,493.32 | 25,165,640.9 | 13,837,025.08 | 29,311,766.86 |
| 应付职工薪酬 | 8,002,074.65 | 25,726,012.38 | 32,804,820.54 | 25,836,273.75 |
| 应交税费 | 59,581,584.51 | 70,666,290.59 | 70,801,663.81 | 68,035,275.74 |
| 其他应付款合计 | 1,374,595,271.56 | 1,238,903,144.53 | 1,107,134,987.94 | 1,257,292,743.82 |
| 应付股利 | - | - | - | 128,611,549.44 |
| 其他流动负债 | 2,085,531.05 | 3,257,247.16 | 1,791,591.69 | 3,796,086.54 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,714,116,520.03 | 1,608,688,119.36 | 1,430,606,229.11 | 1,614,610,036.88 |
| 非流动负债: | | | | |
| 长期应付款 | 1,925,490 | 1,925,490 | 1,925,490 | 1,925,490 |
| 递延收益 | 154,570,746.01 | 126,155,318.28 | 76,618,901.07 | 77,965,362.64 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 156,496,236.01 | 128,080,808.28 | 78,544,391.07 | 79,890,852.64 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,870,612,756.04 | 1,736,768,927.64 | 1,509,150,620.18 | 1,694,500,889.52 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 584,748,452 | 584,748,452 | 584,597,952 | 584,597,952 |
| 资本公积 | 111,793,377.69 | 111,793,377.69 | 122,074,041.01 | 122,074,041.01 |
| 减:库存股 | 62,255,152 | 48,135,010 | 64,698,480 | 64,698,480 |
| 盈余公积 | 292,813,413.08 | 292,813,413.08 | 292,813,413.08 | 292,813,413.08 |
| 未分配利润 | 4,399,621,756.7 | 4,251,576,797.98 | 4,064,264,460.33 | 3,990,459,077.93 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,326,721,847.47 | 5,192,797,030.75 | 4,999,051,386.42 | 4,925,246,004.02 |
| 少数股东权益 | 182,636,569.69 | 187,755,709.13 | 187,665,868.62 | 184,606,482.37 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,509,358,417.16 | 5,380,552,739.88 | 5,186,717,255.04 | 5,109,852,486.39 |
| 负债和股东权益合计 | 7,379,971,173.2 | 7,117,321,667.52 | 6,695,867,875.22 | 6,804,353,375.91 |
| 公告日期 | 2024-04-13 | 2024-03-11 | 2023-10-26 | 2023-07-13 |
| 审计意见(境内) | | 标准无保留意见 | | |